Genprex Inc Biotech Stock to Watch

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=F-R6oUQpsSQ

Justin Introduces Genprex, Inc. (NASDAQ:GNPX) • Genprex, Inc. ( Genprex or the Company ) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) for the Company's lead drug candidate, REQORSA® Immunogene Therapy, in combination with Genentech, Inc.'s Tecentriq® in patients with extensive-stage small cell lung cancer (ES-SCLC) who did not develop tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. • (NASDAQ:GNPX) • Report➡️ https://finance.yahoo.com/news/genpre... • Trade With Justin ➡️ https://thealgo.com • Business Inquiry ➡️ [email protected] • Disclaimer: This video is not investment advice. For our full disclaimer, please visit https://blazecapital.com/disclaimer • Sponsored Content - Blaze Capital was compensated $2000 USD for advertising services by a 3rd party for an advertising package that includes this video. Blaze Capital does not own a position in Genprex. (NASDAQ:GNPX)

#############################

New on site